anmelden
BX Swiss TOP 30 CHF
1.508,52
PKT
-1,02
PKT
-0,07
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.10.12 | Straumann hold | Vontobel Research | |
| 30.10.12 | UBS buy | Vontobel Research | |
| 30.10.12 | Geberit hold | Vontobel Research | |
| 30.10.12 | UBS halten | Independent Research GmbH | |
| 29.10.12 | Holcim hold | Deutsche Bank AG | |
| 29.10.12 | Holcim hold | Deutsche Bank AG | |
| 29.10.12 | Nestlé kaufen | Hamburger Sparkasse AG (Haspa) | |
| 29.10.12 | Novartis halten | Independent Research GmbH | |
| 29.10.12 | UBS overweight | J.P. Morgan Cazenove | |
| 29.10.12 | Sonova buy | Vontobel Research | |
| 29.10.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 29.10.12 | Swiss Re buy | Vontobel Research | |
| 29.10.12 | Schindler hold | Vontobel Research | |
| 29.10.12 | UBS neutral | UBS AG | |
| 29.10.12 | Julius Bär buy | UBS AG | |
| 29.10.12 | UBS hold | Vontobel Research | |
| 29.10.12 | UBS neutral | Sarasin Research | |
| 29.10.12 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
| 29.10.12 | Novartis outperform | Credit Suisse Group | |
| 26.10.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 26.10.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 26.10.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Logitech neutral | UBS AG | |
| 26.10.12 | UBS neutral | Nomura | |
| 26.10.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 26.10.12 | UBS neutral | Exane-BNP Paribas SA | |
| 26.10.12 | UBS equal-weight | Morgan Stanley | |
| 26.10.12 | Logitech hold | Vontobel Research | |
| 26.10.12 | Novartis reduce | Vontobel Research | |
| 26.10.12 | UBS neutral | Sarasin Research | |
| 25.10.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 25.10.12 | Novartis buy | Sarasin Research | |
| 25.10.12 | UBS hold | Vontobel Research | |
| 25.10.12 | Logitech neutral | Sarasin Research | |
| 25.10.12 | UBS neutral | Sarasin Research | |
| 25.10.12 | ABB (Asea Brown Boveri) neutral | Sarasin Research | |
| 25.10.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 25.10.12 | Novartis reduce | Vontobel Research |
